Showing 1,098 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Pharmaceutical industry

What It Means for Gilead to Launch Its Own Generics for Hepatitis C Treatments

Editor's pick
24/7 Wall St.
25 September 2018
Pharmaceutical industry

Gilead to launch generic versions of its hepatitis drugs

Editor's pick
Reuters
25 September 2018
Access to healthcare

Brazil court strips Gilead hepatitis drug patent, politician says

Editor's pick
Reuters
25 September 2018
Hepatitis C treatment

Overwhelming evidence shows hepatitis C treatment effective for people who inject drugs

Editor's pick
EurekAlert
21 September 2018
Pharmaceutical industry

EPO Upholds Gilead Patent On Hep C Medicines, But In Amended Form

Editor's pick
Intellectual Property Watch
16 September 2018
Pharmaceutical industry

Groups Call for End to Gilead’s Unwarranted Hepatitis C Drug Monopoly in Europe

Editor's pick
MSF press release
11 September 2018
Hepatitis C treatment

South Africa: Almost half of injecting drug users surveyed have contracted Hepatitis C

Editor's pick
Bhekisisa
15 August 2018
Hepatitis C treatment

Fewer Australians are dying from hepatitis C, but thousands are still missing out on treatment

Editor's pick
ABC News
13 August 2018
Hepatitis C treatment

Fighting hepatitis C demands more than cheap drugs

Editor's pick
SciDev.Net
30 July 2018
Hepatitis C treatment

Supervised drug consumption sites offer opportunities for HCV testing and treatment

News
27 July 2018
People who inject drugs

France: the changing characteristics of people living with HIV on hepatitis C treatment

Editor's pick
AVERT
17 July 2018
Hepatitis C treatment

Using hepatitis C-infected donor kidneys could reduce time on dialysis for transplant patients with HCV

Editor's pick
Eurekalert Inf Dis
10 July 2018
Hepatitis C treatment

State Prisons Fail To Offer Cure To 144000 Inmates With Deadly Hepatitis C

Editor's pick
Kaiser Health News
9 July 2018
Hepatitis & HIV

Coinfection Connection

Editor's pick
POZ
27 June 2018
Access to healthcare

MSF challenges Gilead's undeserved patent in China on lifesaving hepatitis C medicine

Editor's pick
MSF press release
20 June 2018
Hepatitis C treatment

Just 12 countries worldwide on track to eliminate hepatitis C infection by 2030

Editor's pick
CDA Foundation
18 June 2018
Hepatitis C treatment

Private Payers Deny Hepatitis C Drug Coverage to 52% of Members

Editor's pick
Health Payer Intelligence
14 June 2018
Hepatitis C treatment

10 patients safely receive hepatitis C-infected lungs in new clinical trial

Editor's pick
CTV
14 June 2018
Hepatitis C treatment

EATG launches a report on access to HCV-related services in the penitentiary system in Europe

Editor's pick
EATG
23 May 2018
Hepatitis C treatment

Do direct acting antivirals cure chronic hepatitis C?

Editor's pick
BMJ
18 May 2018
Hepatitis C symptoms & diagnosis

Do fatigue and quality of life improve after hepatitis C is cured?

News
16 May 2018
Hepatitis C treatment

How states could be saving more hepatitis C patients

Editor's pick
USC News
15 May 2018
Access to healthcare

Collective Efforts By Civil Society Groups Bar The Way To Hepatitis C Patents

Editor's pick
Intellectual Property Watch
14 May 2018
Pharmaceutical industry

Gilead Topples As Its Hepatitis C Drug Franchise Continues To Crumble

Editor's pick
Investor's Business Daily
2 May 2018